Michael D. West
2013 - BioTime
In 2013, Michael D. West earned a total compensation of $1.6M as Chief Executive Officer at BioTime, a 108% increase compared to previous year.
Compensation breakdown
Bonus | $65,000 |
---|---|
Option Awards | $851,574 |
Salary | $680,315 |
Other | $37,750 |
Total | $1,634,639 |
West received $851.6K in option awards, accounting for 52% of the total pay in 2013.
West also received $65K in bonus, $680.3K in salary and $37.8K in other compensation.
Rankings
In 2013, Michael D. West's compensation ranked 4,599th out of 12,286 executives tracked by ExecPay. In other words, West earned more than 62.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,599 | 63rd |
Manufacturing | 1,573 | 66th |
Chemicals And Allied Products | 456 | 69th |
Drugs | 318 | 73rd |
Biological Products, Except Diagnostic Substances | 49 | 76th |
West's colleagues
We found four more compensation records of executives who worked with Michael D. West at BioTime in 2013.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019